ChEBI
carboxamidine
- Term ID
-
CHEBI:35359
- Synonyms
-
- Definition
-
Compounds having the structure RC(=NR)NR2. The term is used as a suffix in systematic nomenclature to denote the -C(=NH)NH2 group including its carbon atom.
- References
-
- Ontology
-
ChEBI
(
EBI
)
Relationships
- is a type of
-
- has subtype
-
(2R)-[(4-carbamimidoylphenyl)amino]{5-ethoxy-2-fluoro-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl}acetic acid
(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-({(3R)-1-[(1Z)-ethanimidoyl]pyrrolidin-3-yl}oxy)phenyl]propanoic acid
(4-benzylpiperidin-1-yl)-(5-amidinomethyl-3aH-indol-2-yl)methanone
(5S)-2-{2-[(4-bromophenyl)sulfonyl]ethyl}-N-[(trans-4-carbamimidoylcyclohexyl)methyl]-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
(5S)-N-[(trans-4-carbamimidoylcyclohexyl)methyl]-2-(2,2-diphenylethyl)-7-methyl-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
... Show All 61 Terms
(2R)-[(4-carbamimidoylphenyl)amino]{5-ethoxy-2-fluoro-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl}acetic acid
(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-({(3R)-1-[(1Z)-ethanimidoyl]pyrrolidin-3-yl}oxy)phenyl]propanoic acid
(4-benzylpiperidin-1-yl)-(5-amidinomethyl-3aH-indol-2-yl)methanone
(5S)-2-{2-[(4-bromophenyl)sulfonyl]ethyl}-N-[(trans-4-carbamimidoylcyclohexyl)methyl]-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
(5S)-N-[(trans-4-carbamimidoylcyclohexyl)methyl]-2-(2,2-diphenylethyl)-7-methyl-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide
(S)-4-{4-[3-(3-carbamimidoylphenyl)-2-(2,4,6-triisopropylbenzenesulfonamido)propanoyl]piperazin-1-ylcarbonyl}piperidine-1-carboximidamide
1-[N-(naphthalen-2-ylsulfonyl)glycyl-4-carbamimidoyl-D-phenylalanyl]piperidine
2,5-bis(4-amidinophenyl)furan
2,5-bis{[4-(N-ethylamidino)]phenyl}furan
2-[5-(4-carbamimidoylphenyl)furan-2-yl]-1H-benzimidazole-5-carboximidamide
2-formamido-N(1)-(5-phospho-D-ribosyl)acetamidine
3-[(2S)-3-(4-beta-alanylpiperazin-1-yl)-3-oxo-2-{[(2,4,6-triisopropylphenyl)sulfonyl]amino}propyl]benzenecarboximidamide
3-[(7-carbamimidoylnaphthalen-2-yl)methyl]-5-({1-[(1Z)-ethanimidoyl]piperidin-4-yl}oxy)-2-methyl-1H-3,1-benzimidazol-3-ium
3-[(Z)-amino(imino)methyl]-N-[2-(4-benzoyl-1-piperidinyl)-2-oxo-1-phenylethyl]benzamide
3-{(2S)-2-[(2-naphthylsulfonyl)amino]-3-oxo-3-piperazin-1-ylpropyl}benzenecarboximidamide
3-{(2S)-3-(4-acetylpiperazin-1-yl)-2-[(2-naphthylsulfonyl)amino]-3-oxopropyl}benzenecarboximidamide
4,4'-furan-2,4-diyldibenzenecarboximidamide
4-[amino(imino)methyl]-1-[2-(3-ammoniopropoxy)-5-methoxybenzyl]piperazin-1-ium
4-hydroxy-3-[2-oxo-3-(thieno[3,2-b]pyridine-2-sulfonylamino)pyrrolidin-1-ylmethyl]benzamidine
4-hydroxydebrisoquin
4-{5-[4-amino(imino)methylphenoxy]pentyloxy}phenyl-iminomethanamine
4-{5-[4-ammino(imino)methylphenoxy]pentyloxy}phenyl-iminomethanammine
5-hydroxyectoine
7-formamidino-7-deazaguanine
7-{[2-({1-[(1Z)-ethanimidoyl]piperidin-4-yl}oxy)-9H-carbazol-9-yl]methyl}naphthalene-2-carboximidamide
8-(pyrimidin-2-ylamino)naphthalene-2-carboximidamide
A-230 nerve agent
A-232 nerve agent
A-234 nerve agent
acetamidine
acetamiprid
Acrylamidine
benzamidine
carbamimidoylazanium
chlordimeform
cyflufenamid
dabigatran
dabigatran etexilate
debrisoquin
diminazene
ectoine
formamidine
formamidines
fradafiban
guanidine
kasugamycin
L-indospicine
lofexidine
melagatran
N-(carboxymethyl)-3-cyclohexyl-D-alanyl-N-[(4-carbamimidoyl-1,3-thiazol-2-yl)methyl]-L-prolinamide
N-[(1R)-1-(4-carbamimidoylbenzyl)-2-oxo-2-piperidin-1-ylethyl]-N(2)-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-alpha-asparagine
N-[3-(aminomethyl)benzyl]acetamidine
N-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyimidoformamide
nizatidine
oxymetazoline
pentamidine
pyrantel
tegaserod
tetryzoline
tipiracil
triflumizole
Show first 5 Terms
Phenotype
Phenotype resulting from carboxamidine
Phenotype where environments contain carboxamidine
Phenotype modified by environments containing carboxamidine
Human Disease / Model Data